STRO
STRO
NASDAQ · Biotechnology

Sutro Biopharma Inc

$25.03
+0.93 (+3.86%)
As of Mar 31, 3:11 PM ET ·
Analyst Consensus
Buy
16
Analysts
High
Coverage
Buy 11 69%
Hold 4 25%
Sell 1 6%
Price Target
Analyst Price Target -63.2% upside
Low Target $5.69
Average Target $9.21
High Target $10.08
Current Price $25.03
Current
$25.03
Target
$9.21
$5.69 $9.21 avg $10.08
Scenario Analysis
Bear Case
$5.69
-77.3%
Low target
Base Case
$9.21
-63.2%
Avg target
Bull Case
$10.08
+-59.7%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$26.54
-5.7% from high
52-Week Low
$5.23
+378.6% from low
Target vs 52W High
$9.21
-65.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.8%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.0%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +158.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -13.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.7%